RIDLEY CORPORATION LIMITED (RIC)
Share Price Analysis and Chart

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

21/08/2026

1

Buy

$3.25

25.97%

Upon further consideration, UBS maintains its FY27 EBITDA estimate of $190m. EPS forecasts fall -3% for FY27 and -2% for FY28 because of higher finance and corporate costs, before rising 1% in FY29.

Buy is retained, with acquisition synergies, cost savings and network optimisation offering upside, while fertiliser demand, integration and leverage are the major risks.

Target improves to $3.25 (up 5c).

First Read: Ridley Corp's FY26 EBITDA was 3% ahead of expectations, although higher finance costs associated with the Fertiliser acquisition and lease interest resulted in underlying NPAT broadly in line.

Fertiliser Distribution was the standout, with 2H26 EBITDA materially ahead of consensus, offset by softer Stockfeeds and Ingredients.

Operating cash flow was also ahead of expectations and net debt finished below the target range, supported by early Fertiliser sales.

Buy. Target $3.20.

FORECAST
UBS forecasts a full year FY27 dividend of 12.00 cents and EPS of 20.00 cents.
UBS forecasts a full year FY28 dividend of 13.00 cents and EPS of 22.00 cents.

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

24/08/2026

2

Overweight

$3.10

20.16%

Jarden maintains its Overweight recommendation for Ridley Corp with its target price unchanged at $3.10 following a solid operational result where second-half EBITDA beat consensus by 5% and net profit after tax remained in line.

The primary driver of the earnings beat was the fertiliser business benefiting from a sharp surge in urea prices during the Middle East conflict, which successfully offset a miss in the bulk and packaged business.

Management's ongoing thesis centres on continued capacity expansion, efficiency projects, and the turnaround of the acquired IPF business to drive high single-digit EPS growth with upside potential.

The broker's estimates reflect cuts of -7%-12% to FY27 through FY29 earnings per share, though the analyst retains an Overweight rating on valuation grounds.

FORECAST
Jarden forecasts a full year FY27 dividend of 12.00 cents and EPS of 18.50 cents.
Jarden forecasts a full year FY28 dividend of 13.00 cents and EPS of 20.00 cents.